The firm insists its product are appropriate for the protection of public health.Read More
Tags :U.S. Food and Drug Administration
RJR presented insufficient evidence that potential benefit outweighs risks. Read More
Documents suggest FDA actions are guided by politics not science, according to critics. Read More
The Inspector General suggests the agency improve data collection and transparency. Read More
Judge reprimands retailer for focusing on procedural objections rather than the FDA’s mandate to protect health. Read More
The reprimanded companies sell products that look like toys and electronics. Read More
Rather than conducting reviews in silo, the FDA should consider all evidence, says vape lawyer. Read More
The regulatory agency should streamline its PMTA pathway, says Americans for Tax Reform. Read More
Stakeholders share their views of the agency’s performance. Read More
The FDA used questionable statistics to justify its marketing denial, says Neil McKeganey.Read More
